GGrantIndex
← Search

Phase I Unit for Therapeutics Research

$238,436N01FY2016AINIH

Duke University, Durham NC

Investigators

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

View original record on NIH RePORTER →